Skip to search formSkip to main contentSkip to account menu

HA 1077

Known as: HA-1077, HA1077 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Isoquinolinesfasudil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Adipose-derived Mesenchymal Stem Cells Therapy for Cornea Regeneration : A Multiphoton Intravital Study in a Mouse Model
Program Number: 3475 Presentation Time: 11:00 AM–11:15 AM Adipose-derived Mesenchymal Stem Cells Therapy for Cornea Regeneration… 
2013
2013
Targetable and Inhalable Nanoerythrosomes Containing Fasudil , a Rho-kinase Inhibitor , for the Treatment of Pulmonary Arterial Hypertension
SUMMARY: A novel lung homing peptide, CARSKNKDC (CAR), was conjugated with nanoerythrosomes (NERs) containing fasudil, a rho… 
2013
2013
The greatest improvement in hESC survival due to treatment with HA-1077 is seen after two days.
2010
2010
A Comparison of ROCK Inhibitors on Human Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Neuron-Like Cells
Bone marrow-derived mesenchymal stem cells (BM-MSC) are a multipotent cell population that can differentiate into neuron-like… 
2009
2009
RHO-KINASE INHIBITOR INCREASES BLADDER COMPLIANCE IN AN IN VITRO RAT WHOLE BLADDER MODEL
Hypothesis / aims of study Rho-kinase (ROK) is known to be a part of the pathways contributing to the phenomenon of Ca 2… 
1999
1999
The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting of migration and enhancing cell loss of vascular smooth muscle cells
1991
1991
Effects of HA1077, an intracellular calcium antagonist, on neurotransmitter metabolism in rat brainIn Vivo
The effect of HA1077, an intracellular calcium antagonist, on neurotransmitter metabolism in rat brain was investigated in vivo… 
1989
1989
EFFECTS OF A NEW INTRACELLULAR CALCIUM ANTAGONIST, HA1077, AN ISOQUINOLINE DERIVATIVE, ON THE PROLIFERATION OF BOVINE VASCULAR SMOOTH MUSCLE CELLS : Arteriosclerosis : 53 Annual Scientific Meeting…